Literature DB >> 12629132

Abnormally high expression of proteasome activator-gamma in thyroid neoplasm.

Tomohisa Okamura1, Shin-Ichi Taniguchi, Tsuyoshi Ohkura, Akio Yoshida, Hideki Shimizu, Mitsue Sakai, Hiroyuki Maeta, Hiroko Fukui, Yoshihiko Ueta, Ichiro Hisatome, Chiaki Shigemasa.   

Abstract

PA28-gamma is the activator of 20S proteasome, the ATP-dependent proteolytic system that plays an important role in cell cycle progression in various cell types. In this paper, we show the abnormally high expression of PA28-gamma in various thyroid neoplasms. Thyroid samples were obtained from patients with normal thyroid (4 cases) and with the following diseases: papillary adenocarcinoma (13 cases), multinodular goiter (4 cases), and anaplastic carcinoma (1 case). PA28-gamma expression was estimated by immunohistochemical staining and Western blotting. In all of the papillary adenocarcinoma samples, PA28-gamma was abnormally overexpressed, especially in cancer cells existing at the peripheral region of the cancer mass or in cancer cells invading the capsular region surrounding the cancer mass. In cancer cells of these areas, PA28-gamma was predominantly distributed in nucleus rather than in the cytoplasm of cancer cells. On the other hand, no obvious PA28-gamma expression was observed in the adjacent normal thyroid follicular cells. In multinodular goiter, the expression of PA28-gamma was relatively low compared with papillary adenocarcinoma. In anaplastic carcinoma, PA28-gamma was expressed at the highest level, especially in poorly differentiated regions such as squamous metaplasia of anaplastic cancer tissue. Therefore, the PA28-gamma expression seems to be restricted to thyroid cancer cells, especially in the region where the growth rate of cancer cells is accelerated. This result is further confirmed by the fact that C2, alpha-subunit of 20S proteasome, and proliferating cell nuclear antigen are similarly overexpressed in this region. Thus, PA28-gamma might be involved in the regulatory system for the cell cycle. Moreover, the growth of thyroid cancer cell lines was affected by the proteasome inhibitor, clasto-lactacystin beta-lactone. These results demonstrate that PA28-gamma is overexpressed in thyroid cancer, especially in its growth-accelerated cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629132     DOI: 10.1210/jc.2002-021413

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

Review 1.  Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.

Authors:  Rachel Raynes; Laura C D Pomatto; Kelvin J A Davies
Journal:  Mol Aspects Med       Date:  2016-05-04

2.  High expression of REGγ is associated with metastasis and poor prognosis of patients with breast cancer.

Authors:  Fan Chai; Yan Liang; Jiong Bi; Li Chen; Fan Zhang; Youhong Cui; Xiuwu Bian; Jun Jiang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell.

Authors:  Xiaoyi Wang; Shengfen Tu; Jinxiang Tan; Tian Tian; Liang Ran; Jean-Francois Rodier; Guosheng Ren
Journal:  Med Oncol       Date:  2010-05-14       Impact factor: 3.064

4.  Regulation of c-Myc protein stability by proteasome activator REGγ.

Authors:  S Li; C Jiang; J Pan; X Wang; J Jin; L Zhao; W Pan; G Liao; X Cai; X Li; J Xiao; J Jiang; P Wang
Journal:  Cell Death Differ       Date:  2014-11-21       Impact factor: 15.828

5.  Molecular and functional characterization of a putative PA28γ proteasome activator orthologue in Schistosoma mansoni.

Authors:  Cláudia Sossai Soares; Enyara Rezende Morais; Lizandra G Magalhães; Carla Botelho Machado; Érika Bueno de Carvalho Moreira; Felipe Roberti Teixeira; Vanderlei Rodrigues; Timothy P Yoshino
Journal:  Mol Biochem Parasitol       Date:  2013-04-20       Impact factor: 1.759

6.  Upregulation of nuclear PA28γ expression in cirrhosis and hepatocellular carcinoma.

Authors:  Motoi Kondo; Kohji Moriishi; Hiroshi Wada; Takehiro Noda; Shigeru Marubashi; Kenichi Wakasa; Yoshiharu Matsuura; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  Exp Ther Med       Date:  2011-12-14       Impact factor: 2.447

7.  Characterization of a REG/PA28 proteasome activator homolog in Dictyostelium discoideum indicates that the ubiquitin- and ATP-independent REGgamma proteasome is an ancient nuclear protease.

Authors:  Patrick Masson; Daniel Lundin; Fredrik Söderbom; Patrick Young
Journal:  Eukaryot Cell       Date:  2009-05-01

8.  REGγ is associated with multiple oncogenic pathways in human cancers.

Authors:  Jing He; Long Cui; Yu Zeng; Guangqiang Wang; Ping Zhou; Yuanyuan Yang; Lei Ji; Yanyan Zhao; Jiwu Chen; Zhuo Wang; Tieliu Shi; Pei Zhang; Rui Chen; Xiaotao Li
Journal:  BMC Cancer       Date:  2012-02-23       Impact factor: 4.430

9.  UV-induced fragmentation of Cajal bodies.

Authors:  Mario Cioce; Séverine Boulon; A Gregory Matera; Angus I Lamond
Journal:  J Cell Biol       Date:  2006-11-06       Impact factor: 10.539

10.  The proteasome activator PA28γ, a negative regulator of p53, is transcriptionally up-regulated by p53.

Authors:  Zhen-Xing Wan; Dong-Mei Yuan; Yi-Ming Zhuo; Xin Yi; Ji Zhou; Zao-Xu Xu; Jian-Lin Zhou
Journal:  Int J Mol Sci       Date:  2014-02-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.